Increased Advanced Oxidation Protein Products Generation by Cyclosporine-A and Angiotensin II in Human Gingival Fibroblasts – Ex-vivo Study
Introduction: Cyclosporin-A (CsA), an immunosuppressant, induces renal fibrosis and Renin Angiotensin System (RAS) is known to play a major role. CsA has the potential to increase the oxidative stress; specifically through the Advanced Oxidation Protein Products (AOPP) which could possibly stimu...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2017-01-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/9183/22246_CE_[NE]_F(DK)_PF1_(DK_NE)_PFA(DK)_PF2(NE_DK).pdf |
Summary: | Introduction: Cyclosporin-A (CsA), an immunosuppressant,
induces renal fibrosis and Renin Angiotensin System (RAS) is
known to play a major role. CsA has the potential to increase the
oxidative stress; specifically through the Advanced Oxidation
Protein Products (AOPP) which could possibly stimulate fibrosis.
A similar type of pathology occurs even in the gingiva known as
CsA Induced Gingival Overgrowth (CIGO).
Aim: This study was undertaken to estimate the AOPP generation
by Human Gingival Fibroblasts (HGF) under the influence of CsA
and Angiotensin II (Ang II).
Materials and Methods: Six healthy gingival tissue samples
were obtained during crown lengthening procedure and primary
HGF were cultured using enzymatic digestion method. The ideal
non-cytotoxic concentrations of CsA and Ang II were identified
using cytotoxicity assay. Later, HGF were incubated with CsA
and Ang II for 12 hours and AOPP assay was performed at zero
and one hour interval.
Results: There was a statistically significant increase in AOPP
production in both the CsA and Ang II when compared to the
control group with a p value<0.05.
Conclusion: CsA can induce oxidative stress and preventing/
controlling it may be necessary to prevent untoward effect of
the drug. |
---|---|
ISSN: | 2249-782X 0973-709X |